Literature DB >> 2802552

Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia.

J L Burns1, D M Lien, L A Hedin.   

Abstract

Trimethoprim resistance was investigated in cystic fibrosis isolates of Pseudomonas cepacia. Determination of the MIC of trimethoprim for 111 strains revealed at least two populations of resistant organisms, suggesting the presence of more than one mechanism of resistance. Investigation of the antibiotic target, dihydrofolate reductase, was undertaken in both a susceptible strain and a strain with high-level resistance (MIC, greater than 1,000 micrograms/ml). The enzyme was purified by using ammonium sulfate precipitation, gel filtration, and ion-exchange chromatography. Specific activities, molecular weights, isoelectric points, and substrate kinetics were similar for both enzymes. However, the dihydrofolate reductase from the trimethoprim-resistant strain demonstrated decreased susceptibility to inhibition by trimethoprim and increased susceptibility to inhibition by methotrexate, suggesting that these two enzymes are not identical. We conclude that the mechanism of trimethoprim resistance in this strain with high-level resistance is production of a trimethoprim-resistant dihydrofolate reductase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802552      PMCID: PMC172634          DOI: 10.1128/AAC.33.8.1247

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

2.  Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.

Authors:  B J Rosenstein; D E Hall
Journal:  Johns Hopkins Med J       Date:  1980-11

3.  Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia.

Authors:  T R Parr; R A Moore; L V Moore; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.

Authors:  R A Moore; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

5.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.

Authors:  C Chiesa; P H Labrozzi; S C Aronoff
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

8.  Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim.

Authors:  J Flensburg; O Sköld
Journal:  Eur J Biochem       Date:  1987-02-02

9.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

10.  Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.

Authors:  R Gold; E Jin; H Levison; A Isles; P C Fleming
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

View more
  8 in total

1.  Genetic characterization of trimethoprim resistance in Haemophilus influenzae.

Authors:  R de Groot; M Sluijter; A de Bruyn; J Campos; W H Goessens; A L Smith; P W Hermans
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.

Authors:  María Dolores Navarro-Martínez; Enma Navarro-Perán; Juan Cabezas-Herrera; Joaquín Ruiz-Gómez; Francisco García-Cánovas; José Neptuno Rodríguez-López
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 3.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

4.  Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Authors:  J L Burns; D K Clark
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

6.  Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.

Authors:  Paola Guglierame; Maria Rosalia Pasca; Edda De Rossi; Silvia Buroni; Patrizio Arrigo; Giulia Manina; Giovanna Riccardi
Journal:  BMC Microbiol       Date:  2006-07-20       Impact factor: 3.605

7.  Community-acquired urinary tract infections caused by Burkholderiacepacia complex in patients with no underlying risk factor.

Authors:  Laila Nimri; Mamuno Sulaiman; Osama Bani Hani
Journal:  JMM Case Rep       Date:  2017-01-31

8.  Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.

Authors:  Silvia Buroni; Maria R Pasca; Ronald S Flannagan; Silvia Bazzini; Anna Milano; Iris Bertani; Vittorio Venturi; Miguel A Valvano; Giovanna Riccardi
Journal:  BMC Microbiol       Date:  2009-09-17       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.